Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Regulation 28 Report to Prevent Future Deaths sent to his Department on 13 October 2022, which states that from the 25th February 2022 the MHRA investigated the potential signal of immune thrombocytopenia and identified three cases of cerebral venous sinus thrombosis which could possibly be associated with the Astra Zeneca covid-19 vaccine, if he will make an assessment of the reasons for which the MHRA did not receive all of the necessary clinical information to allow them fully to consider these cases; and whether sufficient information has now been provided to the MHRA to allow them to make a full consideration.

Prevention of Future Death reports play a valuable role in drawing matters of concern to the attention of the Government, its agencies and others to determine if action should be taken. The Department ensures that relevant regulators and other bodies are aware of matters of concern brought to its attention so that the system can respond as appropriate, and the Medicines and Healthcare products Regulatory Agency has provided input into the Department's response to this Regulation 28 Report.

The Department is finalising its response to this Regulation 28 report. It is within the Chief Coroner’s discretion to publish the report, together with the Department’s response.